Indian researchers accused of violating ethical guidelinesBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7482.60-d (Published 06 January 2005) Cite this as: BMJ 2005;330:60
- Ganapati Mudur
- New Delhi
Medical experts in India have accused government doctors of violating national guidelines on clinical ethics by treating patients in Mumbai with a new and unproved treatment developed abroad without insisting on parallel studies outside India. Wary of India's attractiveness as a site for clinical trials, the Indian government has maintained a policy of rejecting clinical trials of unproved treatments developed outside India when they are carried out only on Indian patients.
But doctors at the Institute of Immunohaematology, a centre of the Indian Council of Medical Research, used a stem cell therapy developed by a biotechnology firm based in Dublin and London to treat four patients with aplastic anaemia …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial